Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques

Journal article

van Doremalen N. et al, (2020), Nature

An effective multi-pathogen vaccine targeting filoviruses and an arenavirus

Conference paper

Flaxman A. et al, (2019), EUROPEAN JOURNAL OF IMMUNOLOGY, 49, 1690 - 1691

NOVEL METHODS TO DETERMINE LIVER-STAGE MALARIA VACCINE CORRELATES OF PROTECTION: KINETICS, DEEP IMMUNE PHENOTYPING AND TRANSCRIPTOMICS

Conference paper

Noe A. et al, (2019), AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 101, 415 - 415

PRIME-TARGET IMMUNISATION WITH LIVER-STAGE MALARIA VACCINES: A FIRST-IN-HUMAN CHALLENGE TRIAL

Conference paper

Datoo M. et al, (2019), AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 101, 415 - 415

Prime and target immunization protects against liver-stage malaria in mice.

Journal article

Gola A. et al, (2018), Sci Transl Med, 10

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens

Journal article

Ewer K. et al, (2017), Human Vaccines & Immunotherapeutics, 13, 3020 - 3032

Prime and Target Immunization Protects Against Liver-Stage Malaria

Conference paper

Gola A. et al, (2017), JOURNAL OF IMMUNOLOGY, 198

Changes in Serological Immunology Measures in UK and Kenyan Adults Post-controlled Human Malaria Infection

Journal article

Hodgson SH. et al, (2016), Frontiers in Microbiology, 7

Simian adenoviruses as vaccine vectors.

Journal article

Morris SJ. et al, (2016), Future Virol, 11, 649 - 659

Viral vectors as vaccine platforms: from immunogenicity to impact

Journal article

Ewer KJ. et al, (2016), Current Opinion in Immunology, 41, 47 - 54

Load More